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Abstract
Aims: To investigate the use of  diffusion weighted magnetic resonance imaging (DWI) and the apparent diffusion coeffi-
cient (ADC) values in the diagnosis of  hemangioma.
Materials and methods: The study population consisted of  72 patients with liver masses larger than 1 cm (72 focal lesions). 
DWI examination with a b value of  600 s/mm2 was carried out for all patients. After DWI examination, an ADC map was 
created and ADC values were measured for 72 liver masses and normal liver tissue (control group). The average ADC values 
of  normal liver tissue and focal liver lesions, the “cut-off ” ADC values, and the diagnostic sensitivity and specificity of  the 
ADC map in diagnosing hemangioma, benign and malignant lesions were researched.
Results: Of  the 72 liver masses, 51 were benign and 21 were malignant. Benign lesions comprised 38 hemangiomas and 13 
simple cysts. Malignant lesions comprised 9 hepatocellular carcinomas, and 12 metastases. The highest ADC values were 
measured for cysts (3.782±0.53×10-3 mm2/s) and hemangiomas (2.705±0.63×10-3 mm2/s). The average ADC value of  he-
mangiomas was significantly higher than malignant lesions and the normal control group (p<0.001). The average ADC value 
of  cysts were significantly higher when compared to hemangiomas and normal control group (p<0.001). To distinguish 
hemangiomas from malignant liver lesions, the “cut-off ” ADC value of  1.800×10-3 mm2/s had a sensitivity of  97.4% and 
a specificity of  90.9%. To distinguish hemangioma from normal liver parenchyma the “cut-off ” value of  1.858×10-3 mm2/s 
had a sensitivity of  97.4% and a specificity of  95.7%. To distinguish benign liver lesions from malignant liver lesions the 
“cut-off ” value of  1.800×10-3 mm2/s had a sensitivity of  96.1% and a specificity of  90.0%.
Conclusion: DWI and quantitative measurement of  ADC values can be used in differential diagnosis of  benign and ma-
lignant liver lesions and also in the diagnosis and differentiation of  hemangiomas. When dynamic examination cannot dis-
tinguish cases with vascular metastasis and lesions from hemangioma, DWI and ADC values can be useful in the primary 
diagnosis and differential diagnosis. The technique does not require  contrast material, so it can safely be used in patients 
with renal failure . 
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Introduction
Diffusion weighted magnetic resonance imaging (DWI) 
measures the random movement of  water molecules 
in the tissues. The amount of  diffusion determines the 
diffusion coefficient. When measuring the diffusion co-
efficient, it can be affected by the heat of  the tissue, mi-
crocirculation, perfusion, magnetic susceptibility or any 
type of  movement, so, in clinical practice to measure 
diffusion, the apparent diffusion coefficient (ADC) is 
used1,2. DWI is a technique that can be obtained within 
the time of  a single held breath, without requiring con-
trast material and was originally used in neuroradiology 
for early diagnosis of  stroke3-5. In the literature, there 
have been published papers on the application of  DWI 
to abdominal organs6-13.
These studies calculated the apparent diffusion coeffi-
cient of  tissue and lesions from diffusion weighted im-
ages and have shown that the technique could be used 
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for the differential diagnosis. Quantitative evaluations 
were made on images showing the amount of  diffusion 
of  water molecules called ADC maps. ADC combines 
the effects of  capillary perfusion and water diffusion in 
extracellular and extravascular intervals14. As with solid 
lesions and abscess, while the cell density in the lesion 
increases, the diffusion becomes limited; so, cellular 
lesions on DWI with high b values (a factor indicat-
ing MR gradient strength and duration) (b=400-1000 
s/mm2) gain a hyperintense signal property; showing 
low numeric values on the ADC map. As cell density 
decreases, such as in cysts, hemangiomas and necrot-
ic lesions, diffusion is fast and high ADC values were 
found. Using high “b” values, DWI only reflects dif-
fusion, however, low “b” value DWI is comprised of  
both diffusion and perfusion components15.
The aim of  this study was to research the use of  DWI 
and ADC values in the diagnosis of  hemangioma; the 
most frequently observed benign tumor of  the liver, 
and in its differentiation from other benign and malig-
nant lesions.
                                              
Materials and methods
This study was planned prospectively. Ethics committee 
approval was obtained. The study population comprised 
72 patients with liver masses larger than 1 cm (focal 
lesions). Patients with chronic liver disease caused by 
pathological situations other than viral hepatitis, alcohol 
and steatosis, biliary obstruction and metabolic causes 
were excluded. Patients with poor general condition, 
patients over the age of  70, patients without respiratory 
cooperation, and cases with prosthesis, implants or car-
diac pacemakers were not included in the study. In ad-
dition, small-sized (less than 1 cm) lesions with difficult 
locations (proximity to subdiaphragmatic,subcapsular 
and falciform ligaments) were also excluded from the 
study because of  difficulty in ADC measurements. 
Diagnosis of  hemangioma and other benign liver le-
sions were based on previous characteristic computer 
tomography and/or dynamic liver magnetic resonance 
imaging results. No changes in size during 6 months of  
follow up was regarded as hemangiomas or benign liv-
er lesions. A typical hemangiomas were not included in 
the study. Cases with malignant lesions or without char-
acteristic imaging results were confirmed using biopsy 
and histopathological results.
A 1.5 Tesla superconducting MR scanner (Intera, 
Master Gyroscan, Philips Medical Systems, the Neth-
erlands) was used for imaging, which was performed 
without any need for sedation, in a supine position with 
a 4 channel sense body coil over the liver. Before DWI 
measurement, coronal localized and T2A axial imag-
es were obtained. DWI images directed at the upper 
abdomen were taken in all patients and control group 
subjects. As a control group, ADC measurements were 
done from normal liver parenchyma of  72 cases. The 
measurements were taken from parenchyma areas at 
least 1 cm away from the capsule and not crossing ma-
jor vascular structures as far as possible. By selecting 
TR 1523 ms, TE 60 ms, FOV 375 mm, matrix 512×512, 
NEX 4 in the single shot, spin echo, echo planar (SS-
SE-EP) DWI, images with b=0.600 s/mm2 values were 
obtained.
Diffusion weighted images with a “b” value of  600 
s/mm2 were transferred to an independent work sta-
tion (Extended MR Workspace, version 7.1.5.1, Philips 
Medical Systems) for processing and ADC maps were 
created. ADC values of  lesions and normal liver pa-
renchyma (control group) were measured by an expe-
rienced radiologist from these maps. The study was 
planned as a uni-center study and all the measurements 
were done by the same radiologist (O.T.). The radiolo-
gist (O.T.) who measured the ADC values was certainly 
blinded from the diagnosis of  previous imaging of  the 
patients. Circular Region of  Interest (ROI) was used 
for the quantitative analysis of  the ADC value of  the 
normal hepatic parenchyma and lesion. The measured 
area of  ROI was set at approximately 0.5 cm2. At least 3 
measurements were made for every lesion and normal 
liver parenchyma and the average values were recorded. 
Using a water-filled phantom, the accuracy of  the ADC 
measurements was tested. Average ADC values of  nor-
mal liver parenchyma and focal liver lesions, ADC “cut-
off ” values, and the diagnostic sensitivity and specificity 
of  the ADC map for hemangioma, benign and malig-
nant lesions were investigated.
For statistical analysis of  data SPSS 18.0 program was 
used. Age and ADC values were summarized as aver-
age and standard deviation (if  necessary, median and 
minimum-maximum). In situations with two or more 
groups (benign-malignant and control group, heman-
gioma-cyst and control group), and in general com-
parison of  mean ages and ADC measurements, One 
Way Analysis of  Variance was used. For significance of  
these two-way group comparisons, the Scheffe test was 
used. To distinguish mean ADC values of  hemangio-
ma, benign and malignant lesions and to determine a 
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cut-off  point, ROC analysis was completed. For all tests 
the statistical level of  significance was set as 0.05.
Results
Of  72 focal liver masses, 51 were benign and 21 were 
malignant. The benign lesions were hemangiomas 
(n=38) and simple cysts (n=13). Malignant lesions 
were 9 hepatocellular carcinoma (n=9) and metasta-
ses (n=12). The highest ADC values were measured 
in cysts (3.782±0.53×10-3 mm2/s) and hemangio-
mas(2.705±0.63×10-3 mm2/s) (Table 1). The average 
ADC value was 2.912±0.73×10-3 mm2/s for benign 
lesions, 1.250±0.74×10-3 mm2/s for malignant lesions 
and 1.631±1.11×10-3 mm2/s for normal liver parenchy-
ma (Table 1). The average ADC value for hemangioma 
was significantly higher than the averages for malignant 
lesions and the normal control group (p<0.001). The 
average ADC value for cysts was significantly higher 
than the value for hemangioma and the normal con-
trol group (p<0.001). For benign lesions, the average 
ADC value was significantly higher when compared to 
malignant lesions and normal control group (p<0.001). 
For malignant lesions, the average ADC value was sig-
nificantly lower than for benign lesions and the normal 
control group (p<0.001).
Table 1: ADC values of lesions that were measured using b value 600 s/ mm2 
  
  ADC values 
(mm²/sec) 
Number of patients (n) 
Normal liver parenchyma 
  
1,631±1,11×10³                72 
Hemangioma 
  
2,705±0,63×10³                38 
Cyst 
  
3.782±0,53×10³                  13 
Benign lesion 
  
2,912±0,73 x10-3                 51 
Malignant lesion 
  
1,250±0,74 x10-3                 21 
 ADC: apparent diffusion coefficient To distinguish hemangioma from normal liver paren-
chyma the “cut-off ” ADC value of  1.858×10-3 mm2/s 
had a sensitivity of  97.4% and a specificity of  95.7%. 
Distinguishing hemangioma from malignant liver le-
sions, the “cut-off ” ADC value of  1.800×10-3 mm2/s 
had a sensitivity of  97.4% and a specificity of  90.9% 
(Table 2, Fig. 1).
Table 2: Cut-off values for ADC with relevant sensitivity and specificity values 
  




     Specificity 




1,800 x10-3  97,4 90,9 
Differentiation between 
hemangioma and normal 
liver parenchyma 
1,858 x10-3  97,4 95,7 
ADC: apparent diffusion coefficient 
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To distinguish benign liver lesions from normal liver 
parenchyma the “cut-off ” ADC value of  1.844×10-3 
mm2/s had a sensitivity of  96.1% and a specificity of  
95.0% while the “cut-off ” ADC value of  1.504×10-3 
mm2/s to distinguish malignant liver lesions from nor-
mal liver parenchyma had a sensitivity of  88.2% and 
a specificity of  81.8%. The ADC “cut-off ” value to 
distinguish benign liver lesions from malignant liver le-
sions was 1.800×10-3 mm2/s which had a sensitivity of  
96.1% and a specificity of  90.0% (Table 3).
Table 3: Cut-off values for ADC with relevant sensitivity and specificity values 
  




     Specificity 
          (%) 
Differentiation between 
Benign lesion and normal 
liver parenchyma 
1,844 x10-3   96,1 95,0 
Differentiation between 
malignant lesion and 
normal liver parenchyma 
1,507 x10-3   88,2 81,8 
Differentiation between 
benign and malignant 
lesion 
1,800 x10-3  96,1 90,9 
 ADC: apparent diffusion coefficient 
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Discussion
Cavernous hemangioma is the most frequently ob-
served benign liver tumor. Typical hemangioma appears 
hypointense on T1AG and hyperintense on T2AG. He-
mangiomas have higher ADC values than solid lesions 
in the liver and lower ADC values than cysts (Fig. 2). In 
addition, to distinguish cavernous hemangiomas from 
other pathologies, contrast dynamic examination is nec-
essary. Mass characterization with magnetic resonance 
imaging (MRI) can evaluate the general lesion morphol-
ogy, signal intensity and contrast pattern. 
However even if  all the results were evaluated togeth-
er, there might still be an overlap between benign and 
malignant lesions. While dynamic contrast examination 
has become a component of  routine abdominal scans, 
the contrast material used increases costs and carries 
the risk of  side effects. Additionally, in some cases, dis-
tinguishing vascular metastasis from hemangioma is 
not possible even with dynamic examination16. DWI is 
a technique which can be used within the duration of  a 
held breath with no necessity for contrast material, and 
it helps to distinguish the “benign-malignant” nature of  
many focal lesions. This advantage, especially in renal 
failure patients due to the risk of  “nephrogenic system-
ic sclerosis”, is important as it reduces the need for IV 
gadolinium chelate compounds.
Diffusion is the name given to the randomized mi-
croscopic movement of  water molecules. At the mi-
croscopic level, diffusion is known to be a sensitive 
parameter for tissue characterization. Today, the meas-
urement of  diffusion in vivo is possible using DWI and 
ADC measurements17. DWI queries and quantifies the 
movement of  water molecules in tissues and thus the 
image is based on differences in movement in tissues 
which produces contrast. Tissue with high density of  
cell membranes, such as tumors, limits the diffusion of  
water protons. In contrast, water molecules move more 
freely in cystic or necrotic tissues and the water protons 
ADC is defined freely. As a result DWI provides infor-
mation about cellularity and cellular membrane integri-
ty, and even microcapillary perfusion. The presence of  
water diffusion means signal loss of  DWI and corre-
sponds with high ADC values. In contrast tumor cells 
have limited diffusion, producing DWI with high signal 
intensity and correspondingly low ADC values appear.
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Figure 2: Liver right lobe posterior hemangioma
            (A)T2 weighted MR image showing hyper intense lesion
            (B) Fat suppressed T1 weighted image after IV contrast showing 
              compatible hemangioma
            (C) b=600 s/mm2 diffusion weighted image showing hyper intense 
              lesion
            (D) ADC map showing the lesion’s hyper intense signal.
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The development of  echoplanar imaging (EPI), a type 
of  fast MRI method, has shown that, diffusion weight-
ed MRI can be used to evaluate abdominal organs18,19. 
The diffusion properties of  tissues are related to the in-
terstitial free fluid and amount of  permeability. In gen-
eral, more limitation on diffusion is observed in cancer 
tissues. On DWI, the foci of  liver tumors have limited 
diffusion and a reduction in ADC values20,21. In can-
cer tissues, the normal structure of  tissues is disrupted. 
This obstructs the macromolecular movement of  wa-
ter limiting diffusion in cancer cases and thus reduces 
measured ADC.
Our study supports previous studies in showing that 
ADC measurements are significantly different in benign 
and malignant liver masses21,22,7,23,24.
In our study, cysts and hemangiomas had the high-
est ADC values while malignant lesions had lower 
ADC values. The average ADC value for cysts was 
3.782±0.53×10-3 mm2/s while hemangiomas had an av-
erage ADC value of  2.705±0.63×10-3 mm2/s. The av-
erage ADC value of  cysts were statistically significantly 
higher than hemangioma ADC values (p<0.001). All 
simple cysts had higher ADC values than the heman-
gioma average ADC values21,22. In our study, the aver-
age ADC value of  benign lesions was 2.912±0.73×10-3 
mm2/s, whereas the average ADC value of  malignant 
lesions was 1.250±0.74×10-3 mm2/s.
For normal liver parenchyma, the average ADC value 
was 1.631±1.11×10-3 mm2/s. Our study supports pre-
vious studies in finding that ADC values for hemangio-
ma were statistically significantly higher than malignant 
lesions and normal liver parenchyma (p<0.001)20,21. The 
“cut-off ” ADC value to distinguish hemangioma from 
normal liver parenchyma was 1.858×10-3 mm2/s with 
a sensitivity of  97.4% and a specificity of  95.7%. The 
“cut-off ” ADC value to distinguish hemangioma from 
malignant liver lesions was 1.800×10-3 mm2/s with a 
sensitivity of  97.4% and a specificity of  90.9%.
The limitations to our study should be considered. 
Firstly, our study population was relatively small when 
the study groups were divided into subgroups. Second-
ly, another limitation was related with the technique. 
Diffusion weighted examination is made by sequences 
sensitive to respiratory, cardiac or peristaltic physiologi-
cal movements which affect image quality and make the 
evaluation more difficult. Another limitation was the 
spatial resolution of  the sequence which was too low 
for lesions less than 1 cm in size and these lesions were 
not included in the study. New studies using faster par-
allel imaging methods have developed image quality and 
reduced the artifacts due to EPI22. Recently, diffusion 
MR studies using 3 Tesla MR devices have improved 
image quality and new papers are available25. 
On the other hand, diffusion weighted MRI sequence 
can be obtained within the duration of  a single held 
breath (about 24 seconds), the technique itself  requires 
no contrast material. The technique can aid differen-
tial diagnosis of  benign and malignant liver masses in 
cases where conventional sequences cannot be used. 
We think that, this MRI sequence is necessary to com-
plete routine liver MR imaging protocols. We suspect 
the ADC values would be lower for complex cysts like 
abscesses and infestations. Because of  the dense na-
ture of  the cysts, this is not surprising. In T2A images, 
hemangiomas and simple cysts were both seen as hy-
perintense lesions. On diffusion weighted images (with 
high b values), hemangiomas were noticed as hyperin-
tense; however, simple cysts were seen as hypointense 
lesions. After ADC mapping, cysts had higher ADC 
values, whereas hemangiomas had lower ADC values 
than cysts. Without using contrast material, this dif-
ferentiation could be done easily with the aid of  ADC 
measurement.
Conclusion
DWI and quantitative measurement of  ADC values can 
be used in differential diagnosis of  benign and malig-
nant liver lesions. Conventional MR imaging with added 
DWI increases the accuracy of  conventional MR meth-
ods in characterizing benign and malignant lesions. He-
mangiomas have higher ADC values than malignant 
lesions and normal parenchyma, but they have lower 
values ADC values than cysts. DWI and quantitative 
measurement of  ADC values can be used in the diagno-
sis and differentiation of  hemangiomas. In case where 
dynamic examination cannot distinguish vascular me-
tastasis and lesions from hemangioma, DWI and ADC 
values can be useful both in primary and differential di-
agnosis. The technique does not require  contrast mate-
rial, so it can safely be used in patients with renal failure.
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